Navigation Links
New studies examine adverse outcomes associated with obesity and more applicable measures of obesity
Date:5/2/2010

subsequent removal of the balloon under propofol sedation. Balloons were smoothly inserted into the stomach by traction under direct endoscopy vision and were positioned in the upper stomach position. The balloon was filled with a saline solution and methylene blue, to help in locating and removal of the balloon. Patients were followed for five to seven months in a multidisciplinary clinical setting, including a gastroenterologist, endocrinologist, nutritionist, psychologist and psychiatrist. The balloon was removed after the five to seven month observation.

Participants across all obesity grades experienced significant weight loss, losing an average of 9.18 percent of initial weight. Patients with an obesity grade 3 experienced a more significant average weight loss of 12.2 percent of initial weight.

"This study reinforces the concept, efficacy and safety of intragastric balloon procedures for treatment of overweight and obesity," said Dr. Elia. "This is a reversible procedure that can be considered as an alternative weight-loss treatment option, particularly in pre-obese patients with a history of failure in other clinical treatments."

Dr. Elia cautioned that the intragastric balloon and intragastric balloon procedures are not a miracle weight loss method; after the balloon is extracted, weight loss maintenance depends exclusively on a combination of a calorie-restricted diet, physical activity and behavior modification.

Dr. Elia will present these data on Monday, May 3 at 8 a.m. CT in Hall F, Ernest N. Morial Convention Center.

Intragastric Air-Filled Balloon with New Features for Obesity (Bioflex): Preliminary Results (Abstract #W1582)
A new study from the Hospital Srio Libans in Sao Paolo, Brazil, suggests that a new endoscopic method using an air-filled balloon could help obese patients maintain weight loss.

Researchers led by Kiyoshi Hashiba, MD, associate professor of the surgical departme
'/>"/>

Contact: Amy Levey
alevey@gymr.com
202-745-5116
Digestive Disease Week
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Studies Confirm Link Between Breast Density and Cancer
2. New UCSF Studies Reveal that Age-Related Nerve Decline is Associated with Inflammation and Differs by Gender
3. Recent Studies Show MAstertuck℠ Technique Removes Large Amounts of Body Fat without Tummy Tuck Surgery
4. 14 Human Clinical Studies Prove the Efficacy of Tahitian Noni Bioactive Beverages
5. Targeted agent blocked growth of deadly brain cancer in preclinical studies
6. Many Kids Not Fully Informed of Their Role in Cancer Studies
7. Kineta Awarded NIH Grant to Complete Preclinical Studies on Type 1 Diabetes / Multiple Sclerosis Drug Candidate
8. New studies on surgical options in inherited breast cancer show drastic treatment is not always best
9. Statement of Ralph B. Everett, President and CEO, Joint Center for Political and Economic Studies, on House Passage of Health Reform Legislation
10. Studies examine Third Eye Retroscope during colonoscopy
11. Studies Show Significant Increases of C. Difficile Infections (CDI)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... ANGELES, Sept. 30 Actresses and mother-daughter pair Blythe Danner ... Entertainment Industry Foundation (EIF) public service announcement that celebrates the ... of PSAs that all major broadcast networks - ABC, CBS, FOX ... EIF,s iParticipate national initiative to promote service ...
... 30 According to a new,market research report, ,Neurostimulation ... for,neurostimulation products is expected to be worth $3.6 billion ... driven by the multiple treatment,applications of neurostimulation products, and ... Browse 48 market data tables and ...
... Sept. 30 On Tuesday, September 22, 2009, ... largest co-payment assistance organizations, hosted a panel discussion to ... underinsured and the related challenges of reducing financial barriers ... ) , Held at the National Press Club ...
... , SUNNYVALE, Calif., Sept. 30 Palo Alto Networks(TM), the ... selected to present at the Computer Forensics Show 2009, taking ... Julie Starr, a distinguished engineer at Palo Alto Networks, will ... and Control" in the IT Security Track on Oct. 6. ...
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... (bupropion SR/zonisamide SR), the Company,s second late stage investigational ... primary efficacy endpoint by demonstrating statistically significantly greater weight ... placebo. The Company plans to meet with the ...
... CITY, Calif., Sept. 30 Genomic Health, Inc. ... Health,s Chief Operating Officer and Chief Financial Officer, will present ... City, on Tuesday, October 6 at 9:30 a.m. ET. ... the presentation, visit the Investor Relations section of Genomic Health,s ...
Cached Medicine News:Health News:Blythe Danner and Gwyneth Paltrow Ask Americans to Volunteer for Healthier Life in New Public Service Announcement 2Health News:Blythe Danner and Gwyneth Paltrow Ask Americans to Volunteer for Healthier Life in New Public Service Announcement 3Health News:MarketsandMarkets: Global Neurostimulation Market Worth US$10.2 Billion by 2014 2Health News:MarketsandMarkets: Global Neurostimulation Market Worth US$10.2 Billion by 2014 3Health News:HealthWell Foundation(R) Gathers Leading Health Care Stakeholders to Discuss Crisis of the Underinsured 2Health News:HealthWell Foundation(R) Gathers Leading Health Care Stakeholders to Discuss Crisis of the Underinsured 3Health News:Palo Alto Networks to Present at the Computer Forensics Show 2009 2Health News:Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients 2Health News:Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients 3Health News:Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients 4Health News:Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients 5Health News:Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients 6
(Date:1/15/2014)... NEW YORK , January 15, 2014 ... subsidiary, BreedIT Ltd., the exclusive worldwide distributor of highly ... announced that on January 7, 2014, the Company,s board ... Ben-Zion Weiner as its new member of ... Weiner held executive positions with Teva Pharmaceutical Industries Ltd ...
(Date:1/15/2014)... -- MultiCell Technologies, Inc. (OTC Bulletin Board: ... concerning composition of matter, biological targets, mechanism of action, ... This patent application describes a novel ... (VSRNAs) which interfere with the basic homeostatic cellular processes ... than 10 bps, yet are surprisingly capable in their ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 /PRNewswire/ ... research report is available in its catalogue: ... & Forecast – Worldwide Analysis ... Pump Market Analysis ... the market as insulin delivery systems especially ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... Medtronic has been a key participant ... for more than a decade. Previous Medtronic ... for concentrated platelets, as well as to ... for producing platelet-rich plasma (PRP) for a ...
This unique hemostatic seal provides a simple option for beating heart CABG anastomoses, allowing you to use your own hand-suturing technique without the release of cerebral emboli associated with th...
... Biliary Self-Expanding Stent System combines low-profile, high radial ... .018" guide wire compatible stent system provides 6F ... diameters (5.0 - 10.0 mm). Now, with longer ... in five stent lengths (28, 38, 56, 80 ...
... Supreme and Response catheters comprise ... catheters available for electrophysiology procedures. Their ... provide for superior torque response with ... multiple curves and French sizes, Supreme ...
Medicine Products: